Expedia Group Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Expedia Group wird ein jährliches Gewinn- und Umsatzwachstum von 15.4% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 18.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 151% betragen.

Wichtige Informationen

15.4%

Wachstumsrate der Gewinne

18.1%

EPS-Wachstumsrate

Hospitality Gewinnwachstum26.1%
Wachstumsrate der Einnahmen6.6%
Zukünftige Eigenkapitalrendite151.0%
Analystenabdeckung

Good

Zuletzt aktualisiert15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Expedia Group, Inc. (NASDAQ:EXPE) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 09
Expedia Group, Inc. (NASDAQ:EXPE) Just Reported And Analysts Have Been Lifting Their Price Targets

Expedia Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 13
Expedia Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Expedia: A Bigger Rebound Rally Is Coming

Nov 18

Expedia Group, Inc. (NASDAQ:EXPE) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 09
Expedia Group, Inc. (NASDAQ:EXPE) Just Reported And Analysts Have Been Lifting Their Price Targets

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$158?

Oct 29
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$158?

Expedia: B2B Segment Upside

Oct 17

Investors Should Be Encouraged By Expedia Group's (NASDAQ:EXPE) Returns On Capital

Oct 14
Investors Should Be Encouraged By Expedia Group's (NASDAQ:EXPE) Returns On Capital

Expedia Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 13
Expedia Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Expedia: Artificial Unsustainable Growth And Riskier Balance Sheet

Aug 11

With EPS Growth And More, Expedia Group (NASDAQ:EXPE) Makes An Interesting Case

Aug 08
With EPS Growth And More, Expedia Group (NASDAQ:EXPE) Makes An Interesting Case

Expedia Group, Inc.'s (NASDAQ:EXPE) P/E Still Appears To Be Reasonable

Jul 26
Expedia Group, Inc.'s (NASDAQ:EXPE) P/E Still Appears To Be Reasonable

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$130?

Jul 11
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$130?

Expedia: More Potential To Rally Than Its Peers

Jul 04

Expedia: Belt Tightening Will Offset Macro-Driven Vrbo Weakness

Jun 23

There's Been No Shortage Of Growth Recently For Expedia Group's (NASDAQ:EXPE) Returns On Capital

Jun 10
There's Been No Shortage Of Growth Recently For Expedia Group's (NASDAQ:EXPE) Returns On Capital

These 4 Measures Indicate That Expedia Group (NASDAQ:EXPE) Is Using Debt Reasonably Well

May 26
These 4 Measures Indicate That Expedia Group (NASDAQ:EXPE) Is Using Debt Reasonably Well

Expedia: Adapting To The 'New Normal' For Travel, But Consumer Segment Remains Risky

May 23

Expedia Group Q1: Revenue Performance Encouraging, But VRBO Concern Remains

May 09

Expedia: A Confident Buy Before Earnings

Apr 22

Expedia Group: Travelling Toward Recovery And Breakout From The U.S.

Apr 04

Expedia's Next Phase Of Its Post-Pandemic Transition Holds Promise

Mar 22

Book A Trip To Undervaluation With Expedia Group

Mar 15

Buy Expedia As Technical Strength Emerges

Feb 20

We Think Expedia Group's (NASDAQ:EXPE) Robust Earnings Are Conservative

Feb 16
We Think Expedia Group's (NASDAQ:EXPE) Robust Earnings Are Conservative

Expedia Group: Attractive P/E Ratio And Strong B2B Revenue Growth

Feb 11

Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Feb 02
Why Expedia Group, Inc. (NASDAQ:EXPE) Could Be Worth Watching

Expedia Is A Better Buy Than Airbnb

Jan 15

With Expedia Group, Inc. (NASDAQ:EXPE) It Looks Like You'll Get What You Pay For

Jan 02
With Expedia Group, Inc. (NASDAQ:EXPE) It Looks Like You'll Get What You Pay For

Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Dec 03
Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Here's Why Expedia Group (NASDAQ:EXPE) Has Caught The Eye Of Investors

Nov 17
Here's Why Expedia Group (NASDAQ:EXPE) Has Caught The Eye Of Investors

Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 48% Undervaluation?

Nov 02
Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 48% Undervaluation?

Is It Too Late To Consider Buying Expedia Group, Inc. (NASDAQ:EXPE)?

Sep 21
Is It Too Late To Consider Buying Expedia Group, Inc. (NASDAQ:EXPE)?

Here's Why We Think Expedia Group (NASDAQ:EXPE) Is Well Worth Watching

Aug 08
Here's Why We Think Expedia Group (NASDAQ:EXPE) Is Well Worth Watching

Here's Why Expedia Group (NASDAQ:EXPE) Can Manage Its Debt Responsibly

Jul 24
Here's Why Expedia Group (NASDAQ:EXPE) Can Manage Its Debt Responsibly

Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 42% Below Their Intrinsic Value Estimate

Jul 08
Expedia Group, Inc. (NASDAQ:EXPE) Shares Could Be 42% Below Their Intrinsic Value Estimate

Should You Think About Buying Expedia Group, Inc. (NASDAQ:EXPE) Now?

Jun 23
Should You Think About Buying Expedia Group, Inc. (NASDAQ:EXPE) Now?

If EPS Growth Is Important To You, Expedia Group (NASDAQ:EXPE) Presents An Opportunity

May 07
If EPS Growth Is Important To You, Expedia Group (NASDAQ:EXPE) Presents An Opportunity

Expedia Group (NASDAQ:EXPE) Has A Pretty Healthy Balance Sheet

Apr 17
Expedia Group (NASDAQ:EXPE) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 45% Undervaluation?

Mar 27
Is There An Opportunity With Expedia Group, Inc.'s (NASDAQ:EXPE) 45% Undervaluation?

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$108?

Mar 06
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$108?

Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Dec 30
Does Expedia Group (NASDAQ:EXPE) Have A Healthy Balance Sheet?

Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$104?

Dec 04
Should You Investigate Expedia Group, Inc. (NASDAQ:EXPE) At US$104?

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:EXPE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202615,7291,6342,6243,44222
12/31/202514,6651,3722,4163,01230
12/31/202413,5831,1082,1892,87631
9/30/202413,3941,0671,9072,649N/A
6/30/202413,2638082,0062,767N/A
3/31/202413,0638071,6222,412N/A
12/31/202312,8397971,8442,690N/A
9/30/202312,5708421,9002,746N/A
6/30/202312,2608992,3213,124N/A
3/31/202312,0833292,8673,606N/A
12/31/202211,6673522,7783,440N/A
9/30/202211,3284513,2793,907N/A
6/30/202210,6713313,0463,683N/A
3/31/20229,6012153,9084,569N/A
12/31/20218,598-2693,0753,748N/A
9/30/20217,239-9572,4203,078N/A
6/30/20215,781-1,5402,8253,480N/A
3/31/20214,236-1,992-1,558-880N/A
12/31/20205,199-2,687-4,631-3,834N/A
9/30/20207,026-2,199-4,073-3,108N/A
6/30/20209,080-1,569-4,230-3,150N/A
3/31/202011,667-633-1,339-166N/A
12/31/201912,0675651,6072,767N/A
9/30/201911,8795061,1732,281N/A
6/30/201911,5976221,7312,771N/A
3/31/201911,3244401,4882,448N/A
12/31/201811,2234061,0971,975N/A
9/30/201810,9834441,2012,019N/A
6/30/201810,673271N/A1,947N/A
3/31/201810,379327N/A1,833N/A
12/31/201710,060378N/A1,845N/A
9/30/20179,834402N/A1,967N/A
6/30/20179,449330N/A2,227N/A
3/31/20179,059304N/A2,144N/A
12/31/20168,774282N/A1,549N/A
9/30/20168,379190N/A1,370N/A
6/30/20167,736194N/A1,432N/A
3/31/20167,203612N/A1,425N/A
12/31/20156,672764N/A1,368N/A
9/30/20156,330843N/A1,342N/A
6/30/20156,104817N/A1,564N/A
3/31/20155,937457N/A1,447N/A
12/31/20145,763398N/A1,367N/A
9/30/20145,560427N/A1,355N/A
6/30/20145,249341N/A1,042N/A
3/31/20144,959323N/A867N/A
12/31/20134,771233N/A777N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EXPEDas prognostizierte Gewinnwachstum (15.4% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: EXPEDie Erträge des Unternehmens (15.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).

Hohe Wachstumserträge: EXPEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: EXPEDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: EXPEDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EXPEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (151%).


Wachstumsunternehmen entdecken